Evidence map›Paper›PMID 25467569›Full record

ArticleLancet (London, England)2015

Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis.

Mark J Dayer, Simon Jones, Bernard Prendergast, Larry M Baddour, Peter B Lockhart, Martin H Thornhill

3 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Lancet (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 193 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
193citing papers in PubMed, 11 pooled it
39.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03354338 phase2unknown statusnot on this mapstarted 2017, after this paper: background citation

Efficacy of Intensive Periodontal Therapy and Premedication With Oral Amoxicilline on Inflammatory Markers and Bacteremia in Patients With Chronic Periodontitis. A Randomized Controlled Trial.

TypeinterventionalSponsorUniversidad El Bosque, BogotáRan2017 to 2018Enrolled90ConditionsChronic Periodontitis, BacteremiaArmsAmoxicillin, Placebo
NCT05027893 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Efficacy of the Application of Moxifloxacin and Cefixime in Reduction of Inflammatory Sequelae and Complications After Mandibular Third Molar Surgery

TypeinterventionalSponsorUniversity of Novi SadRan2019 to 2023Enrolled157ConditionsPostoperative Complications, Antibiotic Reaction, Antibiotic Side Effect, Antibiotic Resistant InfectionArmsMoxifloxacin 400 mg Oral Tablet, Cefixime 400 mg Oral Tablet, Placebo
NCT06422221 phase4unknown statusnot on this mapstarted 2024, after this paper: background citation

An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures

TypeinterventionalSponsorUniversity of Santiago de CompostelaRan2024 to 2025Enrolled150ConditionsBacteremia, EndocarditisArmsClindamycin, Doxycycline
3 · Its place in the literature

Who cites it

193 citing papers in PubMed, 11 syntheses or guidelines pooled it, 522 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Arquivos brasileiros de cardiologia · 2017
    Guideline
  7. Pooled it
  8. Guideline
  9. Guideline
  10. Epidemiology of infective endocarditis beforeTherapeutic advances in cardiovascular disease
    Pooled it
  11. Prophylactic Antibiotics for Prevention of Infective Endocarditis or Bacteremia in Pediatric Patients With Congenital Heart Disease Undergoing Dental Procedures: Systematic Review.Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
    Pooled it
  12. Trial
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article

133 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Mark J DayerDepartment of Cardiology, Taunton and Somerset NHS Trust, Taunton, Somerset, UK.
Simon JonesIntegrated Care Research, University of Surrey, Guildford, Surrey, UK.
Bernard PrendergastCardiothoracic Services, Department of Cardiology, John Radcliffe Hospital, Oxford, UK.
Larry M BaddourDivision of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA.
Peter B LockhartDepartment of Oral Medicine, Carolinas Medical Center, Charlotte, NC, USA.
Martin H ThornhillDepartment of Oral Medicine, Carolinas Medical Center, Charlotte, NC, USA; Unit of Oral & Maxillofacial Surgery & Medicine, University of Sheffield School of Clinical Dentistry, Sheffield, UK. Electronic address: m.thornhill@sheffield.ac.uk.
Carolinas Medical Center · USJohn Radcliffe Hospital · GBMayo Clinic · USTaunton & Somerset NHS Foundation Trust · GBUniversity of Sheffield · GBUniversity of Surrey · GB

Funding

A Before and After Study of the Effect of Ceasing to Give Antibiotic ProphylaxisR03DE023092 · NIDCR · UNIVERSITY OF SHEFFIELD · PI THORNHILL, MARTIN H · 2013 to 2015
$213k
NIDCR NIH HHS 1R03DE023092-01NIDCR NIH HHS R03 DE023092
6 · The paper itself

Abstract

backgroundAntibiotic prophylaxis given before invasive dental procedures in patients at risk of developing infective endocarditis has historically been the focus of infective endocarditis prevention. Recent changes in antibiotic prophylaxis guidelines in the USA and Europe have substantially reduced the number of patients for whom antibiotic prophylaxis is recommended. In the UK, guidelines from the National Institute for Health and Clinical Excellence (NICE) recommended complete cessation of antibiotic prophylaxis for prevention of infective endocarditis in March, 2008. We aimed to investigate changes in the prescribing of antibiotic prophylaxis and the incidence of infective endocarditis since the introduction of these guidelines.

methodsWe did a retrospective secular trend study, analysed as an interrupted time series, to investigate the effect of antibiotic prophylaxis versus no prophylaxis on the incidence of infective endocarditis in England. We analysed data for the prescription of antibiotic prophylaxis from Jan 1, 2004, to March 31, 2013, and hospital discharge episode statistics for patients with a primary diagnosis of infective endocarditis from Jan 1, 2000, to March 31, 2013. We compared the incidence of infective endocarditis before and after the introduction of the NICE guidelines using segmented regression analysis of the interrupted time series.

findingsPrescriptions of antibiotic prophylaxis for the prevention of infective endocarditis fell substantially after introduction of the NICE guidance (mean 10,900 prescriptions per month [Jan 1, 2004, to March 31, 2008] vs 2236 prescriptions per month [April 1, 2008, to March 31, 2013], p<0·0001). Starting in March, 2008, the number of cases of infective endocarditis increased significantly above the projected historical trend, by 0·11 cases per 10 million people per month (95% CI 0·05-0·16, p<0·0001). By March, 2013, 35 more cases per month were reported than would have been expected had the previous trend continued. This increase in the incidence of infective endocarditis was significant for both individuals at high risk of infective endocarditis and those at lower risk.

interpretationAlthough our data do not establish a causal association, prescriptions of antibiotic prophylaxis have fallen substantially and the incidence of infective endocarditis has increased significantly in England since introduction of the 2008 NICE guidelines.

fundingHeart Research UK, Simplyhealth, and US National Institutes of Health.

Indexed as

Administration, OralAdultAgedAmoxicillinAnti-Bacterial AgentsAntibiotic ProphylaxisClindamycinDental CareDrug PrescriptionsEndocarditisEnglandFemaleHumansIncidenceInterrupted Time Series AnalysisMaleAmoxicillinAnti-Bacterial AgentsClindamycin

Identifiers

PMID25467569
PMCPMC5599216
OpenAlexW2148912816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.